213 related articles for article (PubMed ID: 32555371)
1. Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.
Politikos I; Devlin SM; Arcila ME; Barone JC; Maloy MA; Naputo KA; Ruiz JD; Mazis CM; Scaradavou A; Avecilla ST; Dahi PB; Giralt SA; Hsu KC; Jakubowski AA; Papadopoulos EB; Perales MA; Sauter CS; Tamari R; Ponce DM; O'Reilly RJ; Barker JN
Leukemia; 2021 Mar; 35(3):850-862. PubMed ID: 32555371
[TBL] [Abstract][Full Text] [Related]
2. Sufficient Immunosuppression with Thymoglobulin Is Essential for a Successful Haplo-Myeloid Bridge in Haploidentical-Cord Blood Transplantation.
Lindemans CA; Te Boome LC; Admiraal R; Jol-van der Zijde EC; Wensing AM; Versluijs AB; Bierings MB; Kuball J; Boelens JJ
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1839-45. PubMed ID: 26119367
[TBL] [Abstract][Full Text] [Related]
3. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
[TBL] [Abstract][Full Text] [Related]
4. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162
[TBL] [Abstract][Full Text] [Related]
5. Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
Tsai SB; Rhodes J; Liu H; Shore T; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
Biol Blood Marrow Transplant; 2018 May; 24(5):997-1004. PubMed ID: 29288821
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
[TBL] [Abstract][Full Text] [Related]
7. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
[TBL] [Abstract][Full Text] [Related]
8. Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.
Salas MQ; Atenafu EG; Bautista MR; Prem S; Lam W; Datt Law A; Shaibani ZA; Kim DDH; Michelis FV; Lipton JH; Viswabandya A; Mattsson J; Kumar R
Eur J Haematol; 2020 Jan; 104(1):36-45. PubMed ID: 31549435
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Bensinger WI; Buckner CD; Shannon-Dorcy K; Rowley S; Appelbaum FR; Benyunes M; Clift R; Martin P; Demirer T; Storb R; Lee M; Schiller G
Blood; 1996 Dec; 88(11):4132-8. PubMed ID: 8943847
[TBL] [Abstract][Full Text] [Related]
10. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
11. Haploidentical cord transplantation-The best of both worlds.
van Besien K; Childs R
Semin Hematol; 2016 Oct; 53(4):257-266. PubMed ID: 27788764
[TBL] [Abstract][Full Text] [Related]
12. High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.
Barker JN; Devlin SM; Naputo KA; Skinner K; Maloy MA; Flynn L; Anagnostou T; Avecilla ST; Scaradavou A; Cho C; Dahi PB; Giralt SA; Gyurkocza B; Hanash AM; Hsu K; Jakubowski AA; Papadopoulos EB; Peled JU; Perales MA; Sauter CS; Shah GL; Shaffer BC; Tamari R; Young JW; Roshal M; O'Reilly RJ; Ponce DM; Politikos I
Blood Adv; 2020 Dec; 4(23):6064-6076. PubMed ID: 33290545
[TBL] [Abstract][Full Text] [Related]
13. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
[TBL] [Abstract][Full Text] [Related]
15. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.
Purtill D; Smith K; Devlin S; Meagher R; Tonon J; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Stevens CE; Barker JN
Blood; 2014 Nov; 124(19):2905-12. PubMed ID: 25185264
[TBL] [Abstract][Full Text] [Related]
16. Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
Duléry R; Bastos J; Paviglianiti A; Malard F; Brissot E; Battipaglia G; Médiavilla C; Giannotti F; Banet A; de Wyngaert ZV; Ledraa T; Belhocine R; Sestili S; Adaeva R; Lapusan S; Isnard F; Legrand O; Vekhoff A; Rubio MT; Ruggeri A; Mohty M
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1407-1415. PubMed ID: 30871978
[TBL] [Abstract][Full Text] [Related]
17. Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.
Dahi PB; Barone J; Devlin SM; Byam C; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Hsu SH; Barker JN
Biol Blood Marrow Transplant; 2014 May; 20(5):735-9. PubMed ID: 24462980
[TBL] [Abstract][Full Text] [Related]
18. Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.
Messina G; Giaccone L; Festuccia M; Irrera G; Scortechini I; Sorasio R; Gigli F; Passera R; Cavattoni I; Filippi AR; Schianca FC; Pini M; Risitano AM; Selleri C; Levis A; Mordini N; Gallamini A; Pastano R; Casini M; Aglietta M; Montanari M; Console G; Boccadoro M; Ricardi U; Bruno B;
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1600-7. PubMed ID: 22484666
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
20. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
Yahng SA; Kim JH; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
Biol Blood Marrow Transplant; 2015 Jan; 21(1):119-29. PubMed ID: 25300871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
